Eledon rises on new mid-stage trial data, FDA fast track status for lead drug
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Obamacare crackdown: Why Trump administration is removing 750,000 people from health insurance rolls
The Trump administration plans to remove hundreds of thousands of people from Obamacare rolls over alleged improper enrollment, while suspending brokers.
Syngene Expands Integrated Drug Development and Manufacturing Services with BMS
The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center, Syngene's first dedicated…
Vertex aims for broad kidney disease label ahead of key readout next year
Vertex Pharmaceuticals reported that an experimental kidney disease drug called inaxaplin improved measures on a urine test in two different patient populations, raising optimism ahead of the…
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.
Novo's CEO knows the drugmaker needs to build confidence
LONDON — Many investors were underwhelmed by Novo’s articulation of its strategy at the company’s capital markets day on Monday, and Mike Doustdar knows it. “In some ways, it's good that it's out ...
Ebola: Dambe warrior who took ring by storm is dead
A popular Dambe traditional martial art champion nicknamed Ebola for his ability to subdue opponents inside the ring, Abdurrazak Abdulmumin, has passed away.